Barrett’s oesophagus — the window that exists
Years of acid reflux can change the lining of the lower oesophagus into a more intestine-like lining. That change is called Barrett's oesophagus, and it is a precancerous condition — not cancer, and most people with it never develop cancer.
What makes it valuable is that it can be monitored with endoscopy and treated. When Barrett's develops dysplasia (abnormal cells), endoscopic treatment — radiofrequency ablation or endoscopic resection — can remove it before it ever becomes cancer, without major surgery.
If you have had heartburn most weeks for years, particularly if you are male, over 50, overweight, or a smoker, it is worth asking whether you should have an endoscopy to look for Barrett's. Long-standing reflux is so ordinary that it is rarely investigated — and it is the one route to catching this disease early.
Who is at risk
- Chronic acid reflux (GERD) and Barrett's oesophagus — the main pathway to adenocarcinoma, which is now the more common type in the U.S.
- Obesity, which both worsens reflux and independently raises risk.
- Smoking — raises risk of both main types.
- Heavy alcohol — strongly linked to squamous cell carcinoma, and multiplied by smoking.
- Very hot drinks, and diets low in fruit and vegetables — associated with squamous cell cancer.
- Age and sex — most common after 60, and several times more common in men.
- Prior chest radiation, swallowed caustic injury, achalasia, and some rare inherited conditions.
- Note the split: adenocarcinoma sits in the lower oesophagus and tracks reflux and obesity; squamous cell carcinoma sits higher and tracks tobacco and alcohol.
Finding it early
There is no general population screening, but people with long-standing reflux and additional risk factors may be offered endoscopy to look for Barrett's — which is screening in the way that matters.
Symptoms that need prompt evaluation:
- Difficulty swallowing (dysphagia) — typically starting with solid food, then softer food. This is the classic symptom and, unfortunately, usually means the tumour is already sizeable. It should never be watched and waited on.
- Food sticking, or pain on swallowing.
- Unintentional weight loss, persistent indigestion or heartburn that changes in character, hoarseness, or vomiting blood or black stools.
New difficulty swallowing in an adult warrants endoscopy, not a trial of stronger antacids. That substitution is one of the commonest reasons this cancer is found late.
How it’s diagnosed
Upper endoscopy with biopsy is the definitive test — a camera passed through the mouth under sedation, which sees the lining directly and samples it.
Staging then uses CT of the chest and abdomen, PET/CT, and endoscopic ultrasound, which measures how deeply the tumour has grown through the wall — the single most important local measurement.
Molecular testing matters: HER2, PD-L1 and mismatch repair status guide drug therapy in advanced disease. Ask whether yours has been tested.
Because swallowing and nutrition are already compromised at diagnosis for many people, a dietitian should be involved from the start, and sometimes a feeding tube is planned in advance rather than after weight has already been lost.
Staging explained simply
The oesophagus is a layered tube, so depth of invasion is what drives stage, along with lymph nodes and distant spread. Early tumours confined to the innermost layers can sometimes be removed endoscopically without removing the oesophagus at all — which is a very different life afterwards.
| Stage | What it means in plain words |
|---|---|
| Stage 0 | High-grade dysplasia — abnormal cells confined to the surface lining. Often treated endoscopically, before it is truly cancer. |
| Stage I | Grown into the wall's inner layers, no lymph nodes. |
| Stage II | Deeper into the muscle wall, or a small number of nodes involved. |
| Stage III | Through the wall and/or more lymph nodes involved. Usually treated with chemoradiation then surgery. |
| Stage IV | Spread to distant organs or distant lymph nodes. |
Grading and biology
Graded 1–3 by how abnormal the cells look, with higher grade indicating faster-behaving disease. Type matters more: adenocarcinoma (lower oesophagus, reflux-related) and squamous cell carcinoma (upper and middle, tobacco- and alcohol-related) differ in treatment response — squamous cell cancer is notably more sensitive to chemoradiation, which occasionally allows definitive treatment without surgery.
HER2 positivity opens up targeted therapy in adenocarcinoma; PD-L1 and mismatch repair status guide immunotherapy. These findings meaningfully change options in advanced disease.
How it’s treated
Very early disease (high-grade dysplasia and some stage I tumours) can be treated endoscopically — endoscopic mucosal resection or submucosal dissection, often with ablation of the remaining Barrett's — preserving the oesophagus entirely.
Locally advanced disease is usually treated with chemoradiation followed by surgery. Radiation with chemotherapy shrinks the tumour and improves the chance of complete removal; this combined approach is standard and is radiation-dependent.
Definitive chemoradiation without surgery is a legitimate curative option, particularly for squamous cell cancers of the upper oesophagus and for people who cannot undergo major surgery. Oesophagectomy is a large operation with real long-term consequences for eating, and avoiding it when outcomes are comparable is a genuine choice worth discussing.
Immunotherapy after surgery improves outcomes for those with residual disease after chemoradiation, and immunotherapy plus chemotherapy is standard in advanced disease.
Radiation also relieves symptoms powerfully. When a tumour blocks swallowing, radiation — sometimes with a stent or brachytherapy — can restore the ability to eat, which matters enormously for quality of life.
Where CureRays fits: chemoradiation is central to curative treatment here, and relieving obstruction is some of the most immediately valuable work radiation does.
What the guidelines say
In broad strokes: treat high-grade dysplasia and very early tumours endoscopically; stage with endoscopic ultrasound and PET/CT; treat locally advanced disease with chemoradiation followed by surgery, or with definitive chemoradiation where surgery is not appropriate; add immunotherapy after surgery for residual disease; test for HER2, PD-L1 and mismatch repair in advanced disease; and involve nutrition support from the outset.
Your team will follow national guidelines such as those from the National Comprehensive Cancer Network (NCCN). The above is a plain-language overview of the general approach, not the guideline itself. NCCN publishes free NCCN Guidelines for Patients®.
Outcomes and odds of cure
Source: NCI SEER Cancer Stat Facts: Esophageal Cancer, SEER 21 (excluding IL), 2016–2022. In 2026 an estimated 22,530 people will be diagnosed and about 16,290 will die of it.
| When it is found | Share of cases | 5-year relative survival |
|---|---|---|
| Localized — confined to the oesophagus | 19% | 48.6% |
| Regional — spread to nearby lymph nodes | 32% | 29.1% |
| Distant — spread to other organs | 39% | 5.3% |
| Unstaged | 10% | 15.9% |
These are population statistics from the National Cancer Institute's SEER program. They describe large groups of people, not any one person, and lag current treatment by several years. They cannot predict what will happen to you.
These are difficult numbers and we are not going to dress them up. Two things are nonetheless true: overall 5-year survival has risen from around 5% in the 1970s to about 25% today, and incidence and death rates are both falling (about 0.6% and 1.1% a year, SEER through 2024). The gap between 48.6% for localized disease and 5.3% for distant disease is also the argument for taking reflux and swallowing symptoms seriously.
Side effects and how we watch for them
During chemoradiation: painful swallowing that worsens through treatment, fatigue, nausea, low blood counts and skin reaction. Nutrition is the central battle — weight loss during treatment worsens everything, and a feeding tube placed proactively is a sensible plan rather than a defeat.
Because the oesophagus sits between the heart and lungs, radiation planning deliberately limits dose to both. Radiation pneumonitis and long-term cardiac effects are the concerns that shape technique.
After oesophagectomy: permanent changes to eating — smaller more frequent meals, reflux, dumping syndrome, and often long-term weight loss. This is a major life adjustment and deserves honest discussion beforehand rather than discovery afterwards.
How it is assessed: graded at each visit on a standard scale, with weight and swallowing tracked weekly. Report inability to swallow fluids, fever, chest pain or black stools urgently.
Follow-up, remission and survivorship
Remission means no detectable cancer. Most recurrences appear within the first two years, so surveillance is closest then — clinical review, imaging, and endoscopy where appropriate.
Survivorship is dominated by eating. Nutrition support, management of reflux and strictures (which can often be stretched endoscopically), vitamin B12 and iron monitoring, and weight maintenance all need active attention. Swallowing therapy helps.
If Barrett's remains after endoscopic treatment, surveillance endoscopy continues on a schedule. Stopping smoking and alcohol reduces the risk of a second cancer.
Questions people actually ask
I've had heartburn for years. Should I be checked?
Possibly. Long-standing weekly reflux, particularly with obesity, smoking, male sex or age over 50, is a reasonable indication to discuss endoscopy to look for Barrett's oesophagus. Most people with reflux never develop cancer, but this is the one realistic route to catching it early.
I have Barrett's. Does that mean I'll get cancer?
Most people with Barrett's never do. It is monitored because the risk is raised, not because progression is expected — and if dysplasia appears, endoscopic treatment can remove it before cancer develops.
Food is starting to stick. Can I wait and see?
No. New difficulty swallowing in an adult warrants endoscopy promptly, not stronger antacids. It is the classic symptom, and delay is the main reason this cancer is found late.
Do I have to have my oesophagus removed?
Not always. Very early disease can be treated endoscopically. For some cancers — particularly squamous cell tumours higher up — definitive chemoradiation without surgery is a legitimate curative option. Ask whether it applies to you, because the difference in daily life afterwards is substantial.
Why is everyone so focused on my weight?
Because maintaining nutrition through treatment measurably affects how well you tolerate it and how you recover. Ask for a dietitian early rather than once weight has already been lost.
Informational only, not medical advice — confirm with your care team.
Go deeper on esophageal cancer
Read the full plain-language guide, or ask our team about chemoradiation and swallowing relief.